Sowu Supply Brain Nootropics Nsi 189 Powder CAS 1270138-40-3 Nsi 189

Name: Sowu Supply Brain Nootropics Nsi 189 Powder CAS 1270138-40-3 Nsi 189
Brand: Xi'an Sowu Biotech Co., Ltd.
SKU: 2090407982

Shaanxi, ChinaXi'an Sowu Biotech Co., Ltd.

US$3.00-5.70

10 gram

Sample price:US$5.70/gram.Request sample

Product profile

Customization

Available

Powder

Yes

Customized

Model NO.

SWP-C131

Certification

GMP, HSE, ISO 9001, USP, BP, SGS

Suitable for

Adult

State

Powder

Purity

>99%

MOQ

10g

Shelf Life

2 Years

Test Method

HPLC

Appearance

off-White Powder

CAS

1270138-40-3

Stock

Yes

Assay

99.6%

OEM

Yes

Mf

C22h30n4o

MW

366.5

Einecs

1592732-453-0

Kind

Nootropics

Solubility

Soluble in DMSO

Grade

Pharmaceutical Grade

Sample

Yes

Transport Package

Vacuum Sealed Foil Bag

Specification

10g/bag

Trademark

Sowu

Origin

China

Production Capacity

100kg/Month

Company profile

Xi'an Sowu Biotech Co., Ltd.

Shaanxi, China

Business Type: Trading CompanyExport Year: 2013-03-01Average Response Time: ≤6.18hTerms of Payment: T/T, Western Union, Money Gram, etc.International Commercial Terms(Incoterms): FOB, EXW, CIF, DAT, DDP, DAP, CFR, CIP

AI-Powered supplier vetting

SummaryThe supplier specializes in technology development and synthetic materials sales with a significant export focus, primarily to Europe and North America. Despite lacking private mold designs and ODM services, it offers customization based on samples and designs. Financial and production data suggest stability, yet innovation and certification areas are lacking. The supplier operates from Shaanxi, China, with no overseas facilities, and has a limited after-sales service framework.

Supplier typeThe supplier operates as a factory located in Shaanxi, China, involved in wholesale and retail industries, focusing on technology development and synthetic materials.

CertificationsThe supplier does not hold any certifications for management systems.

After-Sales capabilityThere is no structured procedure for assessing or documenting service capabilities or corrective actions, indicating limited after-sales service capability.

Financial creditThe supplier demonstrates consistent financial data over recent years, suggesting stable financial capacity.

R&D capabilityThe supplier lacks new product launches, ODM services, and SDK availability, indicating limited innovation capability.

Production capacityThe supplier has a robust production output between US$50 Million - US$100 Million and maintains a consistent lead time, reflecting reliable production capability.

Customization capabilityThe supplier provides customization services from samples and designs, even without private mold designs or 3D design services.

Client casesThe supplier has been exporting for four years, with 90% of sales from exports to Europe and North America.